Ronald Sokovich
Urology · Watertown, WINPI 1396796074
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,893 of the $2,781 with a category attached, or 68.1%. Astellas Pharma US Inc accounts for 60.6% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $805 and has fallen 77.9% since, to $178 in 2025.
Across 128 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$2K
- Pfizer$198
- AbbVie$172
- Urovant Sciences Inc$83
- Medtronic$81
- Sumitomo Pharma America, Inc.$64
- plus $497 from 19 others
What the payments were for
- Food & beverage$1,89368%
- Education$88832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 66 | $1,685 |
| Pfizer | 11 | $198 |
| AbbVie | 10 | $172 |
| Urovant Sciences Inc | 5 | $83 |
| Medtronic(2 entities) | 4 | $81 |
| Sumitomo Pharma America, Inc. | 4 | $64 |
| Myriad Genetic Laboratories, Inc. | 3 | $64 |
| 180 Medical, Inc. | 2 | $49 |
| Urogen Pharma, Inc. | 3 | $44 |
| Davol Inc. | 1 | $40 |
| Rochester Medical Corporation | 2 | $33 |
| Bayer | 2 | $30 |
| Axonics, Inc. | 2 | $29 |
| Olympus America Inc. | 1 | $25 |
| Cook Medical LLC | 1 | $22 |
| Boston Scientific | 2 | $21 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Coloplast | 1 | $16 |
| Merck | 1 | $15 |
| Tolmar Pharmaceuticals, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Teleflex LLC | 1 | $14 |
| Laborie Medical Technologies Corp. | 1 | $14 |
How this compares
$2,781 in reported general payments places this provider in the 75th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 150 | $112,801 |
| OrgovyxRelugolix | 12 | $30,392 |
| GemtesaVibegron | 26 | $15,002 |
| Tamsulosin Hcl | 444 | $6,464 |
| Methenamine Hippurate | 116 | $6,101 |
| Finasteride | 288 | $3,559 |
| Solifenacin Succinate | 39 | $1,798 |
| Desmopressin Acetate | 13 | $1,122 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $503 |
| Oxybutynin Chloride ErOxybutynin Chloride | 33 | $457 |
| Oxybutynin Chloride | 25 | $334 |
| Ciprofloxacin Hcl | 66 | $272 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $93 |
| Amoxicillin | 24 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,685 | $112,801150 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $64 | $45,39538 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 215 urology providers in Wisconsin.
Other urology in Watertown
- Dan GralnekMadison$142K
- Amy GuiseMilwaukee$106K
- Christopher ManakasMadison$87K
- Bahareh Alavi-DunnGreen Bay$62K
- Javier SantiagoMadison$57K
- Kevin FlynnNeenah$56K
- Margaret KnoedlerMadison$31K
- Jeremy ReesePleasant Prairie$27K
- Edwin AbelMadison$22K
- Christopher WalshWauwatosa$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.